Amgen USA Inc.Usage: REPATHA is indicated for reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease, and as an adjunct to diet and other therapies to lower LDL cholesterol in adults and pediatric patients (ages 10+) with primary hyperlipidemia, heterozygous, or homozygous familial hypercholesterolemia.